AURINIA PHARMACEUTICALS INC. - CA05156V1022 (Stock)
Munich
| Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
|---|---|---|---|---|---|---|
7,06 EUR
|
0,00% | 13.06.2025 08:00 | - | - | - | - |
| Contact | |
|---|---|
|
|
Aurinia Pharmaceuticals Inc. , , |
| Phone | |
| Fax | |
| Internet | |
| IR Contact/PR Contact | -/- |
| Symbol | |
| End of financial year | 31.12.2025 |
| Issued capital | 949.903.073,205 EUR |
| Shareholders |
|---|
| Board | |
|---|---|
| Dr. Daniel Billen | Chairman of Supervisory Board |
| Dr. David Jaynee | Member of Supervisory Board |
| Dr. Karen Smith | Member of Supervisory Board |
| Jeffrey Bailey | Member of Supervisory Board |
| Jill Leversage | Member of Supervisory Board |
| R. MacKay-Dunn | Member of Supervisory Board |
| Dr. Brinda Balakrishnan | Member of Supervisory Board |
| Dr. Robert Foster | Member of Supervisory Board |
| Activity Description |
|---|
| - |
© 2000 - 2025 UniCredit Bank Austria AG. Please read our terms and conditions
Implemented and powered by FactSet
Fond data is provided from Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
